August 24, 2023 Comments Off on New patent expiration for Takeda Pharms drug VYVANSE Posted in: Uncategorized
Annual Drug Patent Expirations for VYVANSE Vyvanse is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from one supplier. There are eighteen…
The post New patent expiration for Takeda Pharms drug VYVANSE appeared first …
August 24, 2023 Comments Off on New patent for Therakind drug JYLAMVO Posted in: Patent Added Annual Drug Patent Expirations for JYLAMVO Jylamvo is a drug marketed by Therakind and is included in one NDA. The generic ingredient in JYLAMVO is methotrexate. Additional details are available…
The post New patent for Therakind drug JYLAMVO appeared …
